Frailty in Vascular Patients Undergoing Surgery

February 7, 2023 updated by: Imperial College London

Vascular Frailty - An Observational Cohort Study

An observational cohort study of the frailty of vascular surgery patients undergoing intervention and their outcomes.

Study Overview

Detailed Description

Vascular surgical operations are major procedures with significant associated morbidity and mortality. Frailty is a major factor influencing surgical outcome, but the effect on morbidity/mortality and quality of life is poorly understood in vascular surgery. Activity levels play a significant role in frailty and in pre-intervention preparation. It is anticipated that as frailty levels increase, activity levels decrease. It is hypothesised that vascular surgery patients suffer from a high prevalence of frailty and that increasing frailty will lead to increased morbidity and mortality and decreased quality of life.

This initial study will provide the foundations to identify targets for improvement in degree of frailty, appropriateness for surgery and outcome.

This project aims to:

Assess and quantify the prevalence of frailty as well as recording activity levels in the vascular surgery patient cohort Explore the impact of frailty and pre-op activity on surgical outcomes in the vascular surgical patient cohort to guide surgical treatments as well as future studies aimed at improving frailty and activity and thereby quality of life.

Identification of an appropriate metric of frailty for this population group to include activity, is a secondary aim of this proposal.

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • London, United Kingdom, W68RF
        • Recruiting
        • Imperial College Healthcare NHS Trust
        • Contact:
      • London, United Kingdom, W6 8RF
        • Not yet recruiting
        • Imperial College London

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Consecutive patients attending Vascular Surgery department for aortic aneurysm repair, carotid artery surgery and lower limb revascularisation.

Description

Inclusion Criteria:

  1. All patients attending for aortic aneurysm repair, carotid artery surgery and lower limb revascularisation under the care of the Vascular Surgery team
  2. Willing and able to give informed written consent

Exclusion Criteria:

  1. Those unable to give informed written consent
  2. Those <18 years of age
  3. In the opinion of the investigator unable or unwilling to comply with the requirements of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Carotid Artery Disease
Patients with Carotid Artery Disease. Quality of life and frailty questionnaires
Quality of life and frailty questionnaires
Aneurysmal Disease
Patients with Aneurysmal Disease. Quality of life and frailty questionnaires
Quality of life and frailty questionnaires
Peripheral Artery Disease
Patients with Peripheral Artery Disease. Quality of life and frailty questionnaires
Quality of life and frailty questionnaires

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between electronic Frailty Index and survival and complication rate.
Time Frame: 6 months
Survival and rate of complication correlated with the pre-operative frailty score (electronic Frailty Index).
6 months
Correlation between Q Mortality Index and survival and complication rate.
Time Frame: 6 months
Survival and rate of complication correlated with the pre-operative frailty score (Q Mortality Index).
6 months
Correlation between ACS Risk Calculator Score and survival and complication rate.
Time Frame: 6 months
Survival and rate of complication correlated with the pre-operative frailty score (ACS Risk Calculator).
6 months
Correlation between V-Possum and survival and complication rate.
Time Frame: 6 months
Survival and rate of complication correlated with the pre-operative frailty score (V-Possum).
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Activity Levels Pre and Post Surgery as measured by the General Practice Physical Activity Questionnaire
Time Frame: 6 months
General Practice Physical Activity Questionnaire will be used to assess patient reported activity before and after surgery.
6 months
Quality of Life Pre and Post Surgery as measure by the EuroQoL EQ-5D questionnaire
Time Frame: 6 months
EuroQol EQ-5D Quality of Life questionnaire will be used to assess patient reported quality of life before and after surgery.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Alun H Davies, DM FRCS, Imperial College London

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2021

Primary Completion (ANTICIPATED)

October 1, 2024

Study Completion (ANTICIPATED)

October 1, 2025

Study Registration Dates

First Submitted

September 4, 2018

First Submitted That Met QC Criteria

September 10, 2018

First Posted (ACTUAL)

September 13, 2018

Study Record Updates

Last Update Posted (ACTUAL)

February 8, 2023

Last Update Submitted That Met QC Criteria

February 7, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymised data will be allowed to be shared on completion.

IPD Sharing Time Frame

3 years for 5 years

IPD Sharing Access Criteria

Health researcher for non-commerical research

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vascular Diseases

Clinical Trials on Questionnaire

3
Subscribe